Search

everythinglearnresearchcommunity

for

Search:↓

Hair follicle biology advancements may lead to better hair growth disorder treatments.

Anabolic steroids can build muscle and strength but have risks and need more research on their clinical benefits and side effects.

Melatonin may help with sleep issues, depression, and cancer, but more research is needed.

Zinc can be a helpful secondary treatment for certain skin conditions, but more research is needed to guide its use.

Certain genetic markers linked to reproductive potential were identified by their impact on a protein's ability to bind to genes.

Nandrolone and oxandrolone could help treat male health issues like muscle loss and low testosterone.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

Skin reactions are a common reason for emergency visits due to drug allergies, with some severe cases needing intensive care.

The document concludes that managing skin conditions during pregnancy is important and requires specialized care.

Retinoids are effective for various skin conditions and hair loss but have serious side effects, so low doses are recommended.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

PNU157706 reduced rat sperm movement and fertility without affecting offspring health.

Antiandrogens are effective for conditions like prostate cancer and skin issues, but more research is needed to confirm their benefits and minimize side effects.

Finasteride and minoxidil are effective FDA-approved treatments for androgenetic alopecia.

Women's ovarian hormones and adrenal androgens change throughout life, affecting hair loss and health.

Many treatments for hair loss lack proper testing and FDA approval, so their effectiveness is uncertain.

Treatments for hair loss include hormone modifiers, minoxidil, and hair transplant surgery.

Systemic corticosteroids can help treat rapidly spreading vitiligo but require more research for safer use.

Hormones and genetics affect hair growth and patterns, with some changes reversible and others not.

The guideline recommends mental health involvement in diagnosing gender identity disorder and outlines hormone and surgical treatment protocols, emphasizing safety, informed consent, and long-term monitoring.

The Polish Society of Dermatology recommends treatments for alopecia areata that vary by severity, including topical and systemic medications, with long-term maintenance important for management.

Testosterone therapy is generally safe for transmen, improves sexual function, and has manageable health risks with proper monitoring.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

The document concludes that inhalation of oxygen and sumatriptan injections are primary for cluster headaches, indomethacin for paroxysmal hemicrania, and lidocaine and lamotrigine for SUNCT, but SUNCT often resists treatment.

Finasteride helps hair growth and prostate issues but may cause sexual side effects and increase tumor risk.

Systemic glucocorticosteroids are a primary treatment for various skin conditions but require careful management due to potential side effects and relapses.

A new microneedle patch treats hair loss effectively with fewer side effects and less frequent use.

The model and estimator can predict drug exposure in kidney transplant patients well.

Deslorelin may help intact male dogs regrow hair from alopecia X, with a 75% success rate and no side effects.